The United States dialysis services market is anticipated to grow at a CAGR of 4.80% during the forecast period of 2025-2034. The market growth is driven by the increasing prevalence of kidney diseases, technical innovations in treatment alternatives and surge in regulatory approvals across the region.
Base Year
Historical Period
Forecast Period
The increasing demand for dialysis services in the US is driven by rising kidney disease incidence, improved patient access to advanced centers, and expanded insurance coverage, encouraging market growth.
Technological innovations and investment in advanced treatment methods are enhancing dialysis efficacy, patient outcomes, and operational efficiencies, positively shaping the US dialysis services market outlook.
Consolidation trends among major US dialysis providers, supported by favorable regulatory policies and a focus on integrated patient care, are reshaping competitive dynamics and bolstering market sustainability.
Compound Annual Growth Rate
4.8%
2025-2034
*this image is indicative*
Dialysis services provide life-sustaining treatment for individuals with kidney failure by removing waste, excess fluids, and toxins from the blood when the kidneys can no longer function effectively. These services include haemodialysis, performed at specialised centres or home, and peritoneal dialysis, which uses the abdominal lining as a natural filter. Dialysis helps regulate blood pressure and maintain essential electrolyte balance, improving patients’ quality of life. With advancements in technology and accessibility, dialysis services continue to evolve, offering more efficient, patient-friendly options for managing chronic kidney disease and end-stage renal failure.
Advancements in Dialysis Consumables to Strengthen Market Expansion
The growing demand for efficient dialysis consumables and the need for improved treatment efficiency are driving advancements in dialysis product development. For instance, in February 2025, a new distribution agreement introduced single-use bicarbonate cartridges in two sizes (720g and 900g) for dialysis centres, hospital outpatient facilities, and skilled nursing homes. This initiative will enhance supply chain efficiency and ensure better availability of dialysis essentials. The market is expected to benefit from improved treatment consistency, reduced operational challenges, and optimised resource management, contributing to greater accessibility and growth in the U.S. dialysis services sector over the forecast period.
Increasing Regulatory Approvals in Kidney Disease Therapeutics to Boost United States Dialysis Services Market Size
The rising prevalence of hyperphosphatemia among chronic kidney disease (CKD) patients on dialysis and the demand for advanced treatment options are key growth drivers for the dialysis services market. For instance, in November 2024, the FDA accepted the New Drug Application (NDA) for a promising phosphate binder therapy, Oxylanthanum Carbonate (OLC). If approved, OLC could significantly reduce treatment burdens for dialysis patients. The introduction of novel therapeutics will enhance patient outcomes, improve medication adherence, and increase the adoption of innovative treatment solutions, fostering the overall growth of the dialysis services market in the United States.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
United States Dialysis Services Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Dialysis Type
Market Breakup by Service Type
Market Breakup by End User
Hemodialysis to Lead the Segmentation by Dialysis Type
Hemodialysis is poised to dominate the market due to its widespread availability and established infrastructure. As per the analysis by Expert Market Research, the global hemodialysis and peritoneal dialysis market is anticipated to grow at a CAGR of 5.80% during the forecast period of 2025-2034. Hospitals and dialysis centres offer advanced hemodialysis equipment, ensuring efficient treatment for patients with end-stage renal disease (ESRD). The segment benefits from continuous technological advancements, including improved dialysis machines and vascular access techniques. Additionally, insurance coverage and Medicare reimbursements make hemodialysis more accessible to patients. Although home-based peritoneal dialysis is gaining traction, the preference for in-centre treatments due to medical supervision and emergency preparedness strengthens hemodialysis’ market position, driving sustained growth in the forecast period.
In-Centre Dialysis to Lead the United States Dialysis Services Market Segmentation by Service Type
In-centre dialysis dominates the market due to its established infrastructure, expert supervision, and accessibility for patients needing intensive care. Market drivers include rising end-stage renal disease (ESRD) cases, increasing healthcare investments, and expanding insurance coverage. Meanwhile, home dialysis is experiencing rapid growth, driven by patient preference for convenience, cost-effectiveness, and technological advancements in remote monitoring. Government initiatives supporting home-based care further fuel expansion. As in-centre dialysis maintains its stronghold, the shift towards personalized home-based treatment is reshaping the market landscape, ensuring a balanced yet dynamic growth trajectory for the dialysis services market.
Adults to Hold a Substantial Market Value for Segmentation by End User
The adult segment is set to dominate the market share by end user due to the high prevalence of chronic kidney disease (CKD) and ESRD among older populations. Rising cases of diabetes and hypertension, leading causes of kidney failure, are significantly contributing to increased dialysis demand. Medicare support for adult dialysis patients further strengthens this segment’s market position. Additionally, the growing trend of home dialysis among adults, coupled with the expansion of in-centre dialysis facilities, is accelerating market expansion. As healthcare providers continue investing in advanced treatment options, the adult segment remains the primary driver of growth in the market.
The market is regionally dominated by high prevalence of kidney disease in states like California, Texas, and Florida. The Northeast, including New York and Massachusetts, benefits from advanced healthcare infrastructure and strong reimbursement policies. The Midwest is witnessing rapid market growth, driven by expanding dialysis centres and increased access to care in rural areas. The Southern states experience rising dialysis demand due to high rates of diabetes and hypertension. Meanwhile, the Western region sees increasing adoption of home dialysis solutions, supported by innovative healthcare initiatives. These regional dynamics collectively contribute to the market’s steady expansion across the United States.
The key features of the market report comprise funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 2000, U.S. Renal Care Inc. is headquartered in Plano, Texas. It operates over 350 dialysis centres across the United States, providing in-centre haemodialysis, home dialysis, and paediatric dialysis services. The company collaborates with nephrologists and hospitals to deliver high-quality patient care. With a focus on personalised treatment plans, U.S. Renal Care integrates innovative technology and patient education to enhance outcomes. The organisation continues to expand its footprint, ensuring comprehensive renal care services while improving accessibility for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
Established in 1996, Fresenius Medical Care AG is headquartered in Bad Homburg, Germany, with a significant presence in the U.S. dialysis market. The company operates dialysis clinics, providing haemodialysis and peritoneal dialysis services to patients. It also manufactures dialysis equipment, including machines, dialysers, and related products. Fresenius focuses on integrating innovative technologies, enhancing treatment efficiency, and improving patient care outcomes. With a robust research and development division, the company continuously advances renal care solutions. Its extensive dialysis network and medical products make it a key player in the U.S. and global dialysis industry.
Founded in 1999, DaVita Inc. is headquartered in Denver, Colorado. It is a leading dialysis service provider, operating over 2,700 outpatient dialysis centres across the United States. The company specialises in in-centre haemodialysis, peritoneal dialysis, and home dialysis services, catering to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). DaVita is committed to patient-centric care, investing in advanced dialysis technologies and value-based healthcare models. Through strategic collaborations and research initiatives, it continues to enhance dialysis treatment quality, ensuring improved patient outcomes while expanding its presence in the renal healthcare sector.
American Dialysis Center is a well-established provider of dialysis services in the United States, focusing on comprehensive kidney care. The company operates multiple dialysis clinics, offering in-centre haemodialysis and peritoneal dialysis options. With a patient-first approach, American Dialysis Center emphasises quality treatment, advanced dialysis technology, and personalised care plans. The organisation works closely with nephrologists to deliver optimal treatment outcomes. Through continuous expansion and investment in state-of-the-art equipment, it aims to improve accessibility and enhance the quality of life for patients with chronic kidney disease and end-stage renal disease.
Founded in 1905, Emory Healthcare is headquartered in Atlanta, Georgia. It is a premier academic healthcare system affiliated with Emory University, providing a range of dialysis services through its hospitals and clinics. Emory offers advanced renal care, including haemodialysis, peritoneal dialysis, and kidney transplant programmes. With a strong emphasis on research and innovation, Emory Healthcare integrates cutting-edge technology into its dialysis treatments. Its multidisciplinary approach ensures comprehensive patient care, combining nephrology expertise with state-of-the-art medical facilities. Emory remains a leading force in advancing dialysis treatment and kidney disease management in the U.S. healthcare system.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Yale New Haven Health, Columbia Dialysis Centers, St. Luke’s, and Satellite Healthcare.
China Hemodialysis and Peritoneal Dialysis Market
Haemodialysis and Peritoneal Dialysis Market
Sub Saharan Africa Dialysis Market
India Peritoneal Dialysis Market
Philippines Dialysis Market
Peritoneal Dialysis Market
Dialysis Market
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dialysis Type |
|
| Breakup by Service Type |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
